ClinicalTrials.gg
Drug

Loratadine clinical trials

Also written Claritin and SCH 029851.

studies test it
45
open now
6
in phase 3
9
first study started
1995

How each study uses Loratadine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Loratadine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Apr 1993 · CLARITIN · NDA 019658 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Loratadine
21
Loratadine 10 Mg
3
Comparator: loratadine
2
Loratadine (Xisimin [Test Treatment])
2
JNJ-1754415-AAA
2

Brand

Claritin
8

Development codes

SCH 029851
2
SCH 29851
1

In one entry with another drug

Given together, or one or the other

Comparator: montelukast/loratadine
2
Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG)
2
Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)
2

Studies by the year they started

45 studies that test it; most in 2006 (4)

Studies that test Loratadine, by start year
YearStudies
19951
19991
20001
20022
20031
20051
20064
20082
20101
20113
20121
20132
20153
20161
20173
20183
20192
20201
20213
20223
20231
20243
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
10
Phase 2
10
Phase 3
9
Phase 4
11
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 26 · Other 19

Bayer (6) · Organon and Co (5) · Ranbaxy Laboratories Limited (4) · Ain Shams University (2) · Xian-Janssen Pharmaceutical Ltd. (2) · Merck Sharp & Dohme LLC (2) · Noha Mansour (1) · King Edward Medical University (1)

Often tested with

Tested in the same studies.

Montelukast (5) · (+)-pseudoephedrine sulfate (5) · Pseudoephedrine (5) · Famotidine (2) · Gabapentin (1) · Olopatadine (1) · Mometasone Furoate (1) · Acyclovir (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Loratadine.

Studies

Open first, then newest update. How each study uses Loratadine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 45

See all 45 studies that test Loratadine →

Given beside what is tested · 14 — Loratadine is usual care or a partner of the new treatment
As the comparator · 9 — what is tested is compared with Loratadine

Codes

What other systems call Loratadine · ClinicalTrials.gg INT008592

  • MeSH (NLM) D017336LoratadineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7AJO3BO7QNLORATADINEConfirmed FDA, NLM, Wikidata
  • RxNorm 28889Confirmed FDA, Wikidata
  • Wikidata Q424049loratadineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29162LoratadineOne source FDA
  • DrugBank DB00455One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.